Hydrogen Bromide → HCID 71008027, compound
Reaction equation
C[O:2][C:3]1[CH:8]=[C:7]([CH:9]([OH:28])[CH2:10][N:11]2[C:23]3[CH2:22][CH2:21][N:20]4[CH2:24][CH2:25][CH2:26][CH:19]4[C:18]=3[C:17]3[CH:16]=[C:15]([CH3:27])[CH:14]=[CH:13][C:12]2=3)[CH:6]=[CH:5][N:4]=1.Br>>[CH3:27][C:15]1[CH:14]=[CH:13][C:12]2[N:11]([CH2:10][CH:9]([C:7]3[CH:6]=[CH:5][NH:4][C:3](=[O:2])[CH:8]=3)[OH:28])[C:23]3[CH2:22][CH2:21][N:20]4[CH:19]([C:18]=3[C:17]=2[CH:16]=1)[CH2:26][CH2:25][CH2:24]4Participants
Procedure
1-(2-Methoxy-pyridin-4-yl)-2-(9-methyl-1,2,3,4,5,10c-hexahydro-3a,6-diaza-cyclopenta[c]fluoren-6-yl)-ethanol (45 mg, 0.119 mmol) and 47% aqueous HBr (4 mL) and heated at 100° C. for 45 min. The reaction was monitored by TLC and LCMS. After consumption of starting material, the reaction mixture was cooled to RT and basified with ammonia and extracted with EtOAc (2×25 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated and the crude product was purified by reverse phase chromatography to obtain 20 mg of 4-(2-(2,3,5,6-tetrahydro-10-methyl-1H-indolizino[7,8-b]indol-7(11cH)-yl)-1-hydroxyethyl)pyridin-2(1H)-one. 1H NMR (CD3OD, TFA salt) δ (ppm): 7.43 (d, 1H), 7.23 (m, 2H), 7.05 (t, 1H), 6.7 (m, 1H), 6.5 (d, 1H),4.79 (m, 1H), 4.3 (m, 2H), 3.9 (m, 2H), 3.8 (m, 1H), 3.6 (m, 1H), 3.4 (m, 2H), 3.1 (m, 1H), 2.6 (m, 1H), 2.4 (s, 3H), 2.3 (m, 2H), 1.9 (m, 1H). Separation by chiral HPLC provided enantiomers II-132a-b.
Workup
- customAfter consumption of starting material
- extractionextracted with EtOAc (2×25 mL)
- dry with materialThe organic layer was dried over anhydrous sodium sulfate
- concentrationconcentrated
- customthe crude product was purified by reverse phase chromatography
Sources & evidence
- ORD record
- ord-596bf1cdc148489cad89eadea299ec2e
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08791132B2
Reaction notes
Loading…